Human immunodeficiency virus (HCV)
Showing 1 - 25 of >10,000
Human Immunodeficiency Virus (HIV), Hepatitis C (HCV) Trial in New York (Video Format, Health Educator)
Not yet recruiting
- Human Immunodeficiency Virus (HIV)
- Hepatitis C (HCV)
- Video Format
- Health Educator
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 21, 2023
Opioid-Related Disorders, Hepatitis C (HCV), Human Immunodeficiency Virus (HIV) Trial (Harm reduction kiosk)
Not yet recruiting
- Opioid-Related Disorders
- +7 more
- Harm reduction kiosk
- (no location specified)
Dec 9, 2022
Human Immunodeficiency Virus, Hepatitis C, Alcohol Abuse Trial in New York, Saint Petersburg (Computer-based alcohol reduction
Completed
- Human Immunodeficiency Virus
- +2 more
- Computer-based alcohol reduction intervention
- +2 more
-
New York, New York
- +1 more
Oct 31, 2022
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-493 coformulated with ABT-530
- (no location specified)
Jul 9, 2021
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-450/r/ABT-267
- +2 more
- (no location specified)
Jul 8, 2021
HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR
Recruiting
- Hepatitis C Virus Infection
- +2 more
-
Douliu, Taiwan
- +6 more
Feb 23, 2021
Human Immunodeficiency Virus Infection, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)
Not yet recruiting
- Human Immunodeficiency Virus Infection
- +2 more
- Patient Participation Form
- (no location specified)
Mar 3, 2023
Gut Microbiome in People Living With HIV and HBV
Not yet recruiting
- Human Immunodeficiency Virus
- +2 more
- (no location specified)
Nov 8, 2023
Chikungunya Virus Infection Trial (VLA1553)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553
- (no location specified)
Aug 31, 2023
HIV Trial (Information, motivation, behavioral skills treatment arm, Information only control arm)
Not yet recruiting
- HIV
- Information, motivation, behavioral skills treatment arm
- Information only control arm
- (no location specified)
Oct 18, 2023
HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)
Not yet recruiting
- HIV
- +2 more
- Prebiotic
- Probiotic
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 30, 2023
HIV Trial (TM HIV, TM HL)
Not yet recruiting
- HIV Infections
- TM HIV
- TM HL
- (no location specified)
Oct 12, 2023
Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)
Completed
- Chronic Hepatitis C
- Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
- (no location specified)
Jan 15, 2021
HIV, Aging Trial in Winston-Salem (Customized activity plan, Customized nutrition plan)
Not yet recruiting
- HIV
- Aging
- Customized activity plan
- Customized nutrition plan
-
Winston-Salem, North CarolinaAtrium Health Wake Forest Baptist
May 12, 2023
HIV-1-infection Trial in Madrid (BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato)
Completed
- HIV-1-infection
- BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato
-
Madrid, SpainHospital FUNDACIÓN JIMÉNEZ DÍAZ
Nov 2, 2022
Human Immunodeficiency Virus, Smoking Cessation, Smoking, Tobacco Trial in Boston, Chennai (Varenicline, Positively Smoke Free
Not yet recruiting
- Human Immunodeficiency Virus
- +2 more
- Varenicline
- +2 more
-
Boston, Massachusetts
- +1 more
Mar 13, 2023
Human Immunodeficiency Virus Trial in Chicago (brentuximab vedotin, Placebo, ART)
Recruiting
- Human Immunodeficiency Virus
- brentuximab vedotin
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jul 29, 2022
Group B Streptococcal Infection Trial in Kawempe (GBS6)
Recruiting
- Group B Streptococcal Infection
-
Kawempe, UgandaMakerere University, John Hopkins University
Apr 14, 2023
Human Immunodeficiency Virus, HIV Trial (Islatravir, Placebo)
Not yet recruiting
- Human Immunodeficiency Virus
- HIV
- Islatravir
- Placebo
- (no location specified)
Oct 13, 2022
Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)
Not yet recruiting
- Human Immuno-deficiency Virus (HIV) Disease
- Budigalimab
- +3 more
- (no location specified)
Sep 5, 2023
HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))
Enrolling by invitation
- HIV
- Antiretroviral Therapy Interruption(ATI)
-
Washington, District of Columbia
- +1 more
Sep 12, 2022